Pay in 4 interest-free payments of $6.62 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Phase 3 trials are expected to begin around 2027, with the earliest possible market launch estimated at 2030-2031
The mechanisms of action involve modulation of sleep-regulating neurotransmitters and neuroendocrine systems including enhancement of delta wave activity during deep sleep stages, regulation of cortisol and stress hormone rhythms that impact sleep quality, optimization of circadian rhythm signaling for proper sleep-wake cycles, support for melatonin and sleep-promoting pathways, and modulation of pain perception which can interfere with sleep quality
This is unmasking androgenetic alopecia , where sudden overall thinning makes the genetic pattern visible (crown or part-line changes)
Your doctor may also suggest starting with a lower dose and gradually increasing it
Chia, J
